Stephen Unger analyst

Currently out of the existing stock ratings of Stephen Unger, 67 are a BUY (90.54%), 6 are a HOLD (8.11%), 1 are a SELL (1.35%).

Stephen Unger

Work Performance Price Targets & Ratings Chart

Analyst Stephen Unger works with a stock forecast success ratio of 87.36% fulfilled within 133.46 days on average.

Stephen Unger’s has documented 127 price targets and ratings displayed on 13 stocks. The coverage was on Healthcare, Technology, Industrials sectors.

Most recent stock forecast was given on NEO, NeoGenomics at 29-Mar-2022.

Wall Street Analyst Stephen Unger

Analyst best performing recommendations are on OCX (ONCOCYTE CORP).
The best stock recommendation documented was for NEO (NEOGENOMICS) at 1/3/2019. The price target of $14 was fulfilled within 6 days with a profit of $1.86 (15.32%) receiving and performance score of 25.54.

Average potential price target upside

BRKR Bruker BRKS Brooks Automation DHR Danaher NEO NeoGenomics TMO Thermo Fisher Scientific A Agilent Technologies CYRX Cryoport AZTA Azenta VCYT Veracyte GHDX Genomic Health MYGN Myriad Genetics OCX OncoCyte Corp PKI PerkinElmer

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

102

$11.77 (13.04%)

70

1 months 21 days ago

1/2 (50%)

$13.67 (15.48%)

76

Hold

81

$-9.23 (-10.23%)

78

2 months 8 days ago

6/6 (100%)

$1 (1.25%)

168

Buy

90

$-0.23 (-0.25%)

65

2 months 8 days ago

3/4 (75%)

$10 (12.50%)

104

Hold

62

$-28.23 (-31.29%)

79

5 months 19 days ago

4/4 (100%)

$3.26 (5.55%)

290

Sell

59

$-31.23 (-34.61%)

70

6 months 4 days ago

3/3 (100%)

$-1.09 (-1.81%)

236

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Stephen Unger?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?